Top of this page
Skip navigation, go straight to the content Newsroom Newsroom


Spotlight Story

UCB Statement on COVID-19 Outbreak

Patients are at the heart of everything we do, and UCB is committed to helping those impacted by the novel coronavirus, COVID-19. This includes helping patients maintain access to and answering any questions about UCB medicines, as well as putting patient and community care first in all our actions during these uncertain times.

Read More



UCB U.S. News

Apr 2, 2020

UCB completes the acquisition of Ra Pharmaceuticals – to deliver differentiated …

Read more
 Mar 24, 2020

UCB Statement on COVID-19 Outbreak

Read more
 Mar 10, 2020

UCB Supports Indiana University Research on Epilepsy Emergency Room Educational …

Read more